Seegene Introduces Diagnostic Test for Diarrhea

ROCKVILLE, MD, Apr 29 (MARKET WIRE) --
Seegene today introduced the Seeplex(R) Diarrhea ACE Detection test that
provides a novel and fast-acting multiplex PCR diagnostic technique to
simultaneously verify a complex range of pathogens that cause diarrhea.
Based on the company's proprietary DPO (Dual Priming Oligo) technology,
the Seeplex Diarrhea ACE Detection tests for ten bacteria (Salmonella
spp., Shigella spp., Campylobacter spp., Vibrio spp., C. difficile Toxin
B, C. perfringens, Y. enterocolitica, Aeromonas spp., E.coli0157:H7,
Verocytotoxin-producing E.coli) and four viruses (Rotavirus, Norovirus,
Enteric adenovirus, Astrovirus) that cause diarrhea.

By accurately detecting and differentiating diarrhea causing viruses from
bacteria, the Seeplex Diarrhea ACE Detection test will help healthcare
practitioners apply the correct course of treatment for patients at the
earliest possible stage.

Caused by viruses and bacteria, fast and accurate diagnosis is crucial for
the proper treatment of this highly contagious and common disease. The
World Health Organization (WHO) estimates that about three million people
die every year worldwide from diarrhea and its associated complications.
Approximately 1.9 million of these fatalities are children under the age
of five.

"70-80% of infectious diarrhea is caused by viruses, especially Norovirus
and Rotavirus, which are also responsible for most of the food borne
diarrhea outbreaks. Until now there have been no diagnostic methods
capable of detecting these multiple and varied viruses accurately," said
Dr. Jong-Yoon Chun, Founder and CEO of Seegene.

Another 10-20% of diarrhea cases result from bacterial infection. To avoid
unnecessary treatment with general antibiotics that promote drug resistant
bacteria, it is important to accurately differentiate viruses from
bacteria, as well as identify pathogens at the early stage of infection.

Dr. Chun continued, "In the case of bacterial diarrhea, traditional
diagnostic methods are microscopy, ELISA and stool culture, but these
methods have notable limitations in terms of sensitivity, specificity,
ease of use and speed. Taking only six hours to detect either bacterial
or viral infection, Seeplex Diarrhea ACE Detection is an accurate, rapid
and cost-effective diarrhea diagnostic tool that offers a new way for
diagnosing diarrhea."

Seeplex Diarrhea ACE Detection is for research use only.

About Seeplex(R) System: Frontier of Multi-pathogen Detection

Seeplex(R) is a breakthrough multiplexing PCR technology that enables a
new standard in simultaneous multi-pathogen detection. Seeplex works in
combination with automatic detection systems such as Capillary
Electrophoresis and delivers a benchmark in testing accuracy, efficiency
and cost-effectiveness.

About Seegene

Seegene, Inc. is a biotechnology company specialized in molecular
diagnostics and research applications. It holds a novel detection platform
named "Seeplex," which sets a standard in high-throughput and simultaneous
multi-pathogen detection called "multiplexing." Seeplex technology
accurately detects multi-pathogens with high-throughput speed, ultimately
providing the most economical basis for saving time, labor and cost.
Seegene develops, manufactures and markets innovative molecular diagnostic
products and services to a worldwide community. Its mission is to maintain
leadership in molecular diagnostics for infectious diseases, genetics,
pharmacogenetics, and oncology, and chromosomal analyses using innovative
proprietary technologies. For more information please visit
www.seegene.com or call +301-762-9066.

Contacts:
Hyunsoo Kim, Ph.D.
Seegene Inc.
301-762-9066
Email Contact
or
Constantine Theodoropulos
Base Pair Communications
617-816-4397
constantine[at]basepaircomm.com

Copyright 2009, Market Wire, All rights reserved.

-0-